Literature DB >> 34477130

Pooled-analysis of efficacy and safety of minimally invasive versus standard percutaneous nephrolithotomy.

Jun Wu1, Guifeng Sang2, Yuhua Liu3, Ludeng Liu4, Zhipeng Chen4.   

Abstract

BACKGROUND: This study aimed to assess the efficacy and safety of minimally invasive percutaneous nephrolithotomy (MPCNL) versus standard percutaneous nephrolithotomy in patients with renal and upper ureteric stones.
METHODS: We conducted a pooled analysis on randomized controlled trials (RCTs). The eligible RCTs were selected from the following databases: MEDLINE, Embase, Web of Science, and the Cochrane Library. The reference lists of retrieved studies were also investigated.
RESULTS: Our analysis included 10 RCTs with 1612 patients. Pooled data from 10 RCTs revealed the following: stone-free rate (odds ratio = 1.46, 95% confidence interval (CI) [1.12,1.88], P = .004), operative time (mean difference [MD]  = 4.10, 95% CI [-1.37,9.56], P = .14), length of hospital stay (MD = -15.31, 95% CI [-29.43,-1.19], P = .03), hemoglobin decrease (MD = -0.86, 95% CI [-1.19,-0.53], P < .00001), postoperative fever (MD = 0.83, 95% CI [0.49,1.40], P = .49), and urine leakage (MD = 0.59, 95% CI [0.25,1.37], P = .22). Besides, we performed sub-group analysis based on vacuum suction effect and multiple kidney stones. For vacuum suction effect, it revealed the following: stone-free rate in vacuum suction group (P = .007) and in non-vacuum suction group (P = .19). Operative time in vacuum suction group (P = .89), non-vacuum suction group (P = .16). Postoperative fever in vacuum suction group (P = .49), non-vacuum suction group (P = .85).
CONCLUSION: This pooled analysis indicated that MPCNL was a safe and effective method for treating renal stones compared with standard percutaneous nephrolithotomy. Besides, the vacuum suction effect in MPCNL played a more important role. When it comes to multiple or staghorn stones, the longer operative time in MPCNL could not be ignored.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34477130      PMCID: PMC8415934          DOI: 10.1097/MD.0000000000027014

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Since percutaneous nephrolithotomy (PCNL) was first introduced by Fernstrom and Johansson[ in 1976, it had gradually become the standard treatment for kidney stones larger than 2 cm and an acceptable alternative for smaller stones (10–20 mm) of the lower renal pole, when there had unfavorable factors for extracorporeal shock wave lithotripsy. PCNL was used to treat upper ureteral stones when extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy were not indicated or failed.[ This technology was widely used due to its low cost and high stone clearance rate. However, the overall complications rate of PCNL was up to 83%, including bleeding, urine leakage, pain, fever, urinoma, renal vasculature and parenchyma damage, injury to surrounding organs, renal pelvis perforation, sepsis, and death, with bleeding and fever being the most common complications.[ Attempting to reduce complications, miniaturized percutaneous access to the kidney was first described by Jackman et al[ in 1997 in children. Later, the miniaturized tract of PCNL was formally named “MPCNL” by Lahme et al[ in 2001. Meanwhile, the former was named standard percutaneous nephrolithotomy (SPCNL) by most researchers. Theoretically, the injury could be weakened by reducing the size of channels and would bring some potential advantages. However, it cannot be ignored that smaller tract may impede stone fragmentation and extraction. When the pressure in the renal pelvis is increased due to the small tract, systemic irrigation fluid containing endotoxins or bacteria may be more readily absorbed, resulting in postoperative fever and sepsis.[ No consensus has been reached on whether minimally invasive percutaneous nephrolithotomy (MPCNL) is as safe and effective as SPCNL. Although a meta-analysis in 2015 demonstrated that MPCNL achieved a similar stone clearance rate as SPCNL, reduced the bleeding, and did not increase the risk of complications, most studies included were non-randomized controlled trials (RCTs) with a small sample size, which may have influenced their conclusions.[ Numerous novel technologies for breaking and retrieving stones have recently been applied to PCNL, and the operator has become more skilled. The high pressure and difficulty in breaking and removing stones have been well handled. Up to now, numerous new high-quality RCTs comparing MPCNL to SPCNL have been conducted. Therefore, we conducted a new pooled analysis using the most recent studies and more abundant data to further evaluate MPCNL's safety and efficacy.

Methods

Search strategy

We searched Embase, Medline, and Cochrane Controlled Trials Register databases, retrieving reference lists of studies to identify RCTs published before October 2020, comparing the safety and efficacy between MPCNL and SPCNL. The following search terms were included: miniaturized percutaneous nephrolithotomy, minimally invasive percutaneous nephrolithotomy, mini-percutaneous nephrolithotomy, mini-tract percutaneous nephrolithotomy, miniaturization percutaneous nephrolithotomy, minimally invasive PCNL, mini percutaneous nephrolithotomy, MPCNL, MINIPCNL, MINI PCNL, MPNL, MINIPNL, MINI PNL, and MINI-PERC.

Inclusion criteria and exclusion criteria

We confirmed inclusion and exclusion criteria before literature search. We included studies that met the following criteria: RCTs comparing MPCNL versus SPCNL; accessible full text of selected studies; patients with renal or upper ureteral calculi; English articles; working sheath outer diameter size in MPCNL was at a range of 14F to 22F; and the study should provide at least 1 of the outcome measures which could be analyzed as mentioned below: stone-free rate (SFR), operative time, hospital stay length, fever, hemoglobin decrease, and urine leakage. Articles with the following exclusion criteria were eliminated: duplicate articles; reported data were clearly erroneous or incomplete; conference abstract; pediatric and obese patients; and did not meet the inclusion criteria.

Quality assessment

The recommended tool in the Cochrane Handbook for Systematic Reviews of Interventions was utilized to assess the risk of bias in each included study. We evaluated each study according to the following entries: random sequence generation, allocation concealment, blinding of participants and personnel, blinding outcome assessment, incomplete outcome data, selective reporting, and other biases. In addition, each entry was classified as “low risk”, “unclear risk”, and “high risk”. Two reviewers independently assessed the risk of bias for individual studies. Differences were resolved by discussion among authors. We employed a funnel plot of meta-analysis results to detect publication bias.

Data extraction

The following information was extracted from each included study as baseline characteristics: the study's first author, publication year, study country, study during period, inclusion and exclusion criteria, SFR definition, intra-operative position, exposure group, and control group treatment, outcomes, and effect indicators. Two reviewers independently extracted the data. In case of disagreement, a third investigator helped resolve disagreement or through discussion.

Statistical analysis

The meta-analysis was conducted using RevMan version 5.3.0 (Cochrane Collaboration, Oxford, UK). The mean difference (MD) was employed to assess continuous and dichotomous outcomes and was evaluated by odds ratio (OR) using a 95% confidence interval (CI). In addition, we analyzed inconsistency using I2 value, which illustrated the proportion of heterogeneity in the study. A random-effect model will be applied for the result if I2 value is >50%. If P value was less than .05, the result was then considered to have statistical significance. No ethical approval was required for this study.

Results

Characteristics of individual studies

Our search retrieved 934 articles, excluding 900 studies after reviewing their titles and abstracts. Then, after a thorough review of the full text, we excluded 24 studies. Finally, 10 RCTs were enrolled,[ of which 3 RCTs used vacuum suctioning device to clean stone fragments,[ and 4 included data of staghorn and multiple kidney stones.[ To determine whether the vacuum effect affected the results, 10 RCTs were divided into 2 sub-groups (vacuum suction group [VSG][ and non-vacuum suction group [NVSG]).[ To determine whether type and quantity of stones affected the results, we extracted SFR and operative time in 4 studies to conduct our meta-analysis.[ Relevant characteristics and baseline of articles are listed in Table 1, and the process of identifying RCTs is displayed in Figure 1.
Table 1

Baseline characteristics and summary of the studies finally included in the systematic review and meta-analysis.

Case, nStone sizeAccess sheath sizeNephroscope sizeLithotripsy
StudyNationStudy periodPositionSFR definition method/timeMPCNLSPCNLMPCNLSPCNLMPCNLSPCNLMPCNLSPCNLMPCNLSPCNL
Cheng F 2010China 2004 to 2007ProneUS and KUB First week after surgery721159.5 cm29.6 cm216F24F8/9.8F20.8FPneumaticPneumatic
Zhong W 2010China 2008 to 2009ProneKUB 1 day after surgery292511.7 cm210.8 cm216F26F8/9.8FNPneumaticPneumatic
Song L 2011China 2008 to 2009ProneKUB and NCCT 3 to 5 days after surgery30308.57 ± 2.25 cm28.65 ± 2.03 cm216F24FN24FHolmium laserUltrasound pneumatic
Sakr A 2017Egypt 2010 to 2013SupineKUB and NCCT 1 day after surgery87812.7 ± 0.2 cm2.6 ± 0.6 cm16.5F30F12F26FPneumaticPneumatic
Karakan T 2016Turkey 2014 to 2016ProneKUB and NCCT 1 month after surgery475020. ± 3.0 mm20.9 ± 3.6 mm14F26F8/9.8F22 to 25FHolmium laserUltrasonic pneumatic
Haghigh R 2017Iran 2016 to 2017ProneKUB and US 48h after surgery353514.26 ± 5.3 mm15.35 ± 5.8 mm16F30F9.8F24FPneumaticPneumatic
Güler A 2018Turkey 2016 to 2017ProneNCCT 1 month after surgery514638.7 ± 13.1 mm38.7 ± 13.1 mm16.5/20F30F12F26FHolmium laser pneumaticHolmium laser pneumatic
Kukreja R.A 2017India2015 to 2017ProneUS and KUB 1 month after surgery616220.6 ± 3.47 mm21.5 ± 3.53 mm17.5F24F12 F20.5 FHolmium laser pneumaticHolmium laser pneumatic
Chuance Du 2018China2009 to 2014ProneKUB and NCCT 3 to 5 days after surgery31129713.6 ± 5.2 cm212.4 ± 6.4 cm216F 18F24F12FNHolmium laserUltrasound
Kandemir E 2019Turkey 2016 to 2018ProneNCCT 3 months after surgery767232.6 ± 8.1 mm33.1 ± 10.9 mm 35:4716.5/20F30F12/14F26FHolmium laserPneumatic ultrasonic

KUB = kidney–urinary–bladder X-ray, MPCNL = minimally invasive percutaneous nephrolithotomy, NCCT = non-contrast computed tomography, SFR = stone-free rate, SPCNL = standard percutaneous nephrolithotomy, US = renal ultrasonography.

Figure 1

A flow diagram of the study selection process.

Baseline characteristics and summary of the studies finally included in the systematic review and meta-analysis. KUB = kidney–urinary–bladder X-ray, MPCNL = minimally invasive percutaneous nephrolithotomy, NCCT = non-contrast computed tomography, SFR = stone-free rate, SPCNL = standard percutaneous nephrolithotomy, US = renal ultrasonography. A flow diagram of the study selection process.

Quality of individual studies

Among 10 RCTs, all articles illustrated random assignment. It was impossible to achieve blind methods because of ethics factor of surgery. Therefore, all trials were evaluated to have a high risk for blinding of patients and practitioners. All studies considered detection bias to be at low risk. No selective reporting of outcomes was observed in the 10 RCTs. Overall, the quality of studies enrolled in this meta-analysis was moderate. A summary of quality assessment results for all trials was illustrated in Figures 2 and 3. The basic symmetry of funnel plots indicated no obvious publication bias in this meta-analysis, as displayed in Figure 4.
Figure 2

A summary of the quality assessment results for all of the trials.

Figure 3

Also a summary of the quality assessment results for all of the trials.

Figure 4

Funnel plot of the studies represented in our analysis. OR = odds ratio, SE: standard error.

A summary of the quality assessment results for all of the trials. Also a summary of the quality assessment results for all of the trials. Funnel plot of the studies represented in our analysis. OR = odds ratio, SE: standard error.

Outcomes and synthesis of results

SFR

SFR was reported in 10 trials (3 in VSG and 7 in NVSG). Due to the lack of significant heterogeneity in both sub-groups, we conducted our analysis using the fixed-effects model. The pooled data from 10 RCTs revealed that SFR in MPCNL group was statistically higher than that in SPCNL group (OR 1.46, 95% CI [1.12,1.88], P = .004). However, differences existed in sub-groups. In VSG, the data indicated that SFR in MPCNL group was statistically higher (OR 1.63, 95% CI [1.14,2.32], P = .007) (Fig. 5).
Figure 5

Forest plots showing changes in SFR. CI = confidence interval, M-H = mantel haenszel, MPCNL = minimally invasive percutaneous nephrolithotomy, NVSG = non-vacuum suction group, SFR = stone-free rate, SPCNL = standard percutaneous nephrolithotomy, VSG = vacuum suction group.

Forest plots showing changes in SFR. CI = confidence interval, M-H = mantel haenszel, MPCNL = minimally invasive percutaneous nephrolithotomy, NVSG = non-vacuum suction group, SFR = stone-free rate, SPCNL = standard percutaneous nephrolithotomy, VSG = vacuum suction group.

Operative time

Operative time was reported in all included RCTs. We used the random-effects model to determine significant heterogeneity. Regarding each sub-group and pooled data, it was demonstrated that the operative time in MPCNL group was comparable to that in SPCNL group. VSG (MD 0.25, 95% CI [–3.11,3.60], P = .89), NVSG (MD 6.17, 95% CI [–2.42,14.75], P = .16), combined group (MD 4.10, 95% CI [–1.37,9.56], P = .14) (Fig. 6A).
Figure 6

Forest plots showing changes in (A) operative time, (B) length of hospital stay, and (C) hemoglobin decrease. CI = confidence interval, IV = inverse variance, MPCNL = minimally invasive percutaneous nephrolithotomy, NVSG = non-vacuum suction group, SD = standard deviation, SPCNL = standard percutaneous nephrolithotomy, VSG = vacuum suction group.

Forest plots showing changes in (A) operative time, (B) length of hospital stay, and (C) hemoglobin decrease. CI = confidence interval, IV = inverse variance, MPCNL = minimally invasive percutaneous nephrolithotomy, NVSG = non-vacuum suction group, SD = standard deviation, SPCNL = standard percutaneous nephrolithotomy, VSG = vacuum suction group.

Length of hospital stay

Length of hospital stay was reported in 6 trials (0 VSG and 6 in NVSG). We used the random-effects model to determine significant heterogeneity. The data revealed that length of hospital stay in MPCNL group was statistically shorter (MD –15.31, 95% CI [–29.43,–1.19], P = .03) (Fig. 6B).

Hemoglobin decrease

Hemoglobin decrease was reported in 7 trials. We used the random-effects model to determine significant heterogeneity. The results revealed that hemoglobin decrease in MPCNL group was statistically fewer (MD –0.86, 95% CI [–1.19,–0.53], P < .00001) (Fig. 6C).

Fever

Postoperative fever was reported in all included RCTs. We used the random-effects model to determine significant heterogeneity. All outcomes revealed no statistical difference between MPCNL and SPCNL groups for postoperative fever. VSG (MD 0.83, 95% CI [0.49,1.40], P = .49), NVSG (MD 0.92, 95% CI [0.55,1.54], P = .76), totally pooled group (MD 0.88, 95% CI [0.61,1.26], P = .48) (Fig. 7A).
Figure 7

Forest plots showing changes in (A) fever and (B) urine leakage. CI = confidence interval, M-H = mantel haenszel, MPCNL = minimally invasive percutaneous nephrolithotomy, NVSG = non-vacuum suction group, SPCNL = standard percutaneous nephrolithotomy, VSG = vacuum suction group.

Forest plots showing changes in (A) fever and (B) urine leakage. CI = confidence interval, M-H = mantel haenszel, MPCNL = minimally invasive percutaneous nephrolithotomy, NVSG = non-vacuum suction group, SPCNL = standard percutaneous nephrolithotomy, VSG = vacuum suction group.

Urine leakage

Urine leakage was contained in 6 trials (0 in VSG and 6 in NVSG). Finding no significant heterogeneity, thus we used the fixed-effects model. There represented no statistical difference between MPCNL and SPCNL group for urine leakage (MD 0.59, 95% CI [0.25,1.37], P = .22) (Fig. 7B).

Discussion

Since the first PCNL was conducted in 1976,[ lithotripsy techniques have been continuously modified in an attempt to increase SFR and decrease morbidity. Electrohydraulic, ultrasonic, and pneumatic/ballistic energy sources were initially considered, followed by holmium laser applied to lithotripsy.[ Besides, vacuum suction effect was also introduced into various lithotripsy platforms such as EMS Lithoclast Trilogy,[ laser suction handpieces,[ Nagele Modular MIP System,[ patented lithotripsy suctioning/clearance system,[ and intelligent controlled perfusion and aspiration system.[ These systems could use vacuum suction effect to retrieve fragments instead of grasping forceps and stone baskets,[ potentially decreasing renal pelvis pressure, providing a clear vision, and improving stone removal efficiency.[ Miniaturization was another advancement in PCNL, as it was the initial attempt to minimize blood loss and injury during PCNL. Recently, it was widely accepted that SPCNL was performed using access sheaths larger than 22F, and MPCNL had a working sheath at a range of 14F to 22F.[ There were also other PCNL types with smaller tracts of such as “micro-PNL”, “super-mini-PNL (SMP)”, “ultra-mini-PNL (UMP)”, and “Mini-micro-PCNL”.[ Generally, indications for SPCNL could be applied to MPCNL, while the latter had additional indications. It could break residual fragments from standard PCNL and deal with pediatric cases. Regarding those with tracts smaller than 14F, although they may be less invasive, they were recommended for small kidney stones, specific locations of kidney stones, or pediatric cases. As a result, SPCNL and MPCNL were the most widely used and adapted.[ Since the concept of miniaturization was developed, the shortcomings of MPCNL have always included poor vision, difficulty of breaking, retrieving stone fragments, high intra-pelvic pressure, perfusion fluid syndrome, postoperative fever, and prolonged operative time, as well as the advantages of less invasiveness, less bleeding, and similar SFR.[ Numerous researches were conducted to confirm whether MPCNL was a safe and effective technology, but no consistent conclusion is currently present. The current meta-analysis evaluated efficacy and safety of MPCNL versus SPCNL using SFR, operative time, length of hospital stays, and complications such as fever, urine leakage, and bleeding. SFR was the most important indicator for estimating PCNL's clinical efficacy. The pooled 10 RCTs data revealed that SFR in MPCNL group was statistically higher than that in SPCNL group. SFR of MPCNL was statistically higher in VSG. When we eliminated the vacuum suction effect, SFR of MPCNL remained higher in NVSG and NSMG, but no statistically significant difference was observed. The results strongly indicated that vacuum suction effect was more important in MPCNL. We considered that the vacuum suction effect, combined with certain characteristics of MPCNL, resulted in a significant improvement in SFR in MPCNL. Listed below are some specific explanations. The negative pressure equipment not only provides a better vision but also contributes to reducing migration of small fragments and retrieves them directly during lithotripsy. Besides, it could also aspirate small fragments when the nephroscope exited to the sheath's tail.[ Numerous features in MPCNL contributed to the fact that fewer stone fragments remain. First, we could nimbly enter narrowed renal calyces in MPCNL to break and retrieve stones.[ Second, using flexible nephroscope in MPCNL also has been demonstrated to be conductive in improving SFR.[ Additionally, less bleeding in MPCNL could also provide a better vision to discover and retrieve fragments.[ Finally, most studies used a holmium laser in MPCNL, and more fragments less than 1 mm could be obtained, allowing it to be easily washed out. Additionally, laser was associated with a lower stone migration rate, reducing the possibility of residual debris being removed to other calyces.[ Consequently, we concluded that applying negative pressure suction equipment, flexible features of MPCNL itself, and laser use have significantly improved SFR in MPCNL. Previous research indicated that MPCNL group had a longer operative time.[ Nevertheless, our article found no statistically significant difference between the 2 groups, despite the operative time in MPCNL group remained longer when all included RCTs were considered. We believed that the following factors contributed objectively to prolonged operative time in MPCNL, but they were well controlled due to constant modification of lithotripsy equipment and surgery technology. The following features of MPCNL could indeed prolong operative time. First, breaking stones into smaller pieces to be suitable for MPCNL prolonged the breaking time, and corresponding large amounts of debris increased the time required to retrieve stones. Second, the bad backflow made surgery more difficult.[ Additionally, lithotripsy with holmium laser also prolonged operative time in MPCNL compared with ultrasonic and pneumatic/ballistic lithotripsy.[ The followings factors contributed to the possibility of reducing. Regarding the NVSG, improved vision due to less bleeding and less chance of fragment migration by a proper technique in MPCNL might reduce the operative time in MPCNL. Regarding VSG, the suction system not only provided a clear surgical vision but also relieved us from repeated manual removal of fragments with perfusion or pliers.[ These comprehensive factors reduced operative time in MPCNL and resulted in a similar operative time in MPCNL and SPCNL. The current meta-analysis revealed a significantly shorter hospital stay length, consistent with a previous study.[ MPCNL typically had a smaller diameter of postoperative nephrostomy tube and a higher tubeless rate.[ Besides, the tube retention time was shorter in MPCNL.[ All these factors contributed to patients experiencing less discomfort, requiring less analgesic, and recovering rapidly following surgery in MPCNL.[ These were the reasons for shorter length of hospital stay in MPCNL. Hemoglobin decrease in MPCNL was fewer in our study, which might be caused by decreased surface area of nephrostomy tract and reduced potential damage to renal parenchymal renal vasculature.[ Additionally, a clear surgical vision and less repeated manual removal of fragments with perfusion or pliers provided by suction equipment, and less chances of multiple tracts in MPCNL group all probably played an important role in reducing bleeding.[ Our meta-analysis revealed no significant difference between MPCNL and SPCNL regarding complications such as postoperative fever and urine leakage. Here were some possible explanations. First, critically selecting patients for PCNL, performing correct intra-operative procedures, treating patients with pre-operative application of antibiotics, and performing first-stage simple nephrostomy could effectively reduce postoperative complications.[ Second, the smaller matched nephroscope was strictly selected, ensuring that the backflow was sufficient to maintain a safe intra-renal pressure most of the time.[ Furthermore, the vacuum effect could reduce renal pelvis pressure, resulting in less endotoxin absorption than previously thought.[ Finally, another possibility should be considered that low morbidity and small sample size led to such results. Although we included 10 high-quality RCTs and performed sub-group analysis, our meta-analysis also had some limitations. First, the sample size remained small, especially when sub-group analysis was performed. Second, the location and size of stones, definition of operation time and length of stay, the time required to determine the residual stone, tract dilation methods, criteria for complete removal of stones, and surgeons’ experience varied across the 10 RCTs, which may have contributed to bias. Finally, additional large-scale and well-designed RCTs are required to confirm our findings.

Conclusions

According to our pooled analysis, MPCNL may achieve a higher SFR, less bleeding, similar operative time, and shorter hospital stay than SPCNL without increasing complications. Overall, MPCNL is a safe and effective technology and can be the first choice for treating kidney stones with the help of vacuum suction effect.

Author contributions

Conceptualization: Guifeng Sang, Zhipeng Chen. Data curation: Jun Wu. Formal analysis: Jun Wu. Investigation: Jun Wu, Yuhua Liu, Ludeng Liu. Resources: Guifeng Sang. Software: Yuhua Liu. Supervision: Zhipeng Chen. Validation: Guifeng Sang. Visualization: Yuhua Liu. Writing – original draft: Jun Wu, Yuhua Liu, Guifeng Sang. Writing – review & editing: Zhipeng Chen.
  32 in total

1.  Percutaneous pyelolithotomy. A new extraction technique.

Authors:  I Fernström; B Johansson
Journal:  Scand J Urol Nephrol       Date:  1976

2.  Comparison of miniaturized percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for the treatment of large kidney stones: a randomized prospective study.

Authors:  Ali Güler; Akif Erbin; Burak Ucpinar; Metin Savun; Omer Sarilar; Mehmet Fatih Akbulut
Journal:  Urolithiasis       Date:  2018-06-01       Impact factor: 3.436

3.  Comparison of renal pelvic pressure and postoperative fever incidence between standard- and mini-tract percutaneous nephrolithotomy.

Authors:  Cheng Wu; Li-Xin Hua; Jian-Zhong Zhang; Xun-Rong Zhou; Wei Zhong; Hao-Dong Ni
Journal:  Kaohsiung J Med Sci       Date:  2016-12-22       Impact factor: 2.744

4.  Should mini percutaneous nephrolithotomy (MiniPNL/Miniperc) be the ideal tract for medium-sized renal calculi (15-30 mm)?

Authors:  Rajesh A Kukreja
Journal:  World J Urol       Date:  2017-11-13       Impact factor: 4.226

Review 5.  Complications in percutaneous nephrolithotomy.

Authors:  Iason Kyriazis; Vasilios Panagopoulos; Panagiotis Kallidonis; Mehmet Özsoy; Marinos Vasilas; Evangelos Liatsikos
Journal:  World J Urol       Date:  2014-09-14       Impact factor: 4.226

6.  Miniperc? No, thank you!

Authors:  Guido Giusti; Alessandro Piccinelli; Gianluigi Taverna; Alessio Benetti; Luisa Pasini; Matteo Corinti; Alessandro Teppa; Silvia Zandegiacomo de Zorzi; Pierpaolo Graziotti
Journal:  Eur Urol       Date:  2006-08-11       Impact factor: 20.096

7.  The modified ultra-mini percutaneous nephrolithotomy technique and comparison with standard nephrolithotomy: a randomized prospective study.

Authors:  Tolga Karakan; Muhammet Fatih Kilinc; Omer Gokhan Doluoglu; Yildiray Yildiz; Cem Nedim Yuceturk; Murat Bagcioglu; Mehmet Ali Karagöz; Okan Bas; Berkan Resorlu
Journal:  Urolithiasis       Date:  2016-05-12       Impact factor: 3.436

8.  Comparison of holmium: Yag laser and pneumatic lithoclast in percutaneous nephrolithotomy.

Authors:  Hammad Afzal Malik; Salman Ahmed Tipu; Nazim Mohayuddin; Gauhar Sultan; Manzoor Hussain; Altaf Hashmi; Syed Ali Anwar Naqvi; Syed Adibul Hasan Rizvi
Journal:  J Pak Med Assoc       Date:  2007-08       Impact factor: 0.781

9.  Suctioning Minimally Invasive Percutaneous Nephrolithotomy with a Patented System Is Effective to Treat Renal Staghorn Calculi: A Prospective Multicenter Study.

Authors:  Chuance Du; Leming Song; Xiaoyuan Wu; Difu Fan; Lunfeng Zhu; Shengfeng Liu; Xiaolin Deng; Tairong Liu; Zhongsheng Yang; Zuofeng Peng; Min Hu; Qigui Liu; Tiejun Pan; Zhiqiang Chen; Zhangqun Ye
Journal:  Urol Int       Date:  2018-04-12       Impact factor: 2.089

Review 10.  EAU Guidelines on Interventional Treatment for Urolithiasis.

Authors:  Christian Türk; Aleš Petřík; Kemal Sarica; Christian Seitz; Andreas Skolarikos; Michael Straub; Thomas Knoll
Journal:  Eur Urol       Date:  2015-09-04       Impact factor: 20.096

View more
  1 in total

1.  Factors Affecting Residual Stone Rate, Operative Duration, and Complications in Patients Undergoing Minimally Invasive Percutaneous Nephrolithotomy.

Authors:  Mladen Doykov; Gancho Kostov; Katya Doykova
Journal:  Medicina (Kaunas)       Date:  2022-03-13       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.